Inhibrx Biosciences annual revenue
2022
2023
2024
2025
Inhibrx Biosciences Revenue Growth & History (INBX)
Inhibrx Biosciences reported $1.3M in revenue for fiscal 2025, an increase of 550.00% from the previous fiscal year.
View full Inhibrx Biosciences company overviewInhibrx Biosciences annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.3M | $1.1M | +550.00% |
| 2024 | 2024-12-31 | $200,000 | −$1.6M | −88.89% |
| 2023 | 2023-12-31 | $1.8M | $499,000 | +38.36% |
| 2022 | 2022-12-31 | $1.3M | — | — |
Inhibrx Biosciences quarterly revenue
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | −$1.3M | −100.00% |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q4 2025 | 2025-12-31 | $0 | −$100,000 | −100.00% |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $1.3M | $1.2M | +1200.00% |
| Q1 2025 | 2025-03-31 | $0 | $0 | — |
| Q4 2024 | 2024-12-31 | $100,000 | — | — |
| Q3 2024 | 2024-09-30 | $0 | −$119,000 | −100.00% |
| Q2 2024 | 2024-06-30 | $100,000 | $70,000 | +233.33% |
| Q1 2024 | 2024-03-31 | $0 | — | — |
| Q3 2023 | 2023-09-30 | $119,000 | — | — |
| Q2 2023 | 2023-06-30 | $30,000 | — | — |
Inhibrx Biosciences revenue growth trends
Inhibrx Biosciences's latest reported quarter, Q2 2026, generated $0 in revenue, a decrease of 100.00% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Inhibrx Biosciences source filings ↗